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Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneu-
monia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins
P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the
structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the
X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic
acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the
N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the
mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology
assays with sera from infected patients were positive when tested against this C-terminal
domain. P40/P90 also showed strong reactivity against human infected sera. The archi-
tectural elements determined for P1 and P40/P90 open new possibilities in vaccine devel-
opment against M. pneumoniae infections.
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M ycoplasma pneumoniae is a human pathogen respon-sible for upper and lower respiratory tract infections1.It is estimated that this bacterium is responsible for up
to 40% of community-acquired pneumonias in persons of all
ages2. In addition to being a severe respiratory pathogen, M.
pneumoniae may induce clinically significant manifestations in
extrapulmonary sites and/or immunologic effects in as many as
25% of the infections3. Unlike for other important respiratory
pathogens, such as Streptococcus pneumoniae and Haemophilus
influenzae, a vaccine for M. pneumoniae is not yet available
despite the considerable efforts4.
M. pneumoniae binds to host target cells by means of a polar
structure known as the attachment organelle, and glides in the
direction of this differentiated structure at a speed of ~1 µm/s
(Fig. 1a)5. Gliding motility in M. pneumoniae and related species
such as Mycoplasma genitalium is caused by a unique mechanism
completely different from the motility of Mycoplasma mobile,
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Fig. 1 The Nap complex in M. pneumoniae. a A phase-contrast immunofluorescence microscopy image of M. pneumoniae cells (left). Locations of the Nap
(surface of the attachment organelle) were visualized by using anti-P1 monoclonal antibody and Alexa Fluor® 546 secondary antibody (red). Bar= 2 µm.
Three-dimensionally printed model of M. pneumoniae cell (right). The positions of the attachment organelle and the Nap structure are indicated. The cell
surface is partly modeled as a transparent canopy to show the internal core structure of the organelle. The arrow indicates gliding direction. b Scheme of
the p1 operon that contains three genes: MPN140, MPN141(p1), and MPN142(orf6). The locations of repetitive elements (RepMPs) in MPN141 and MPN142
are shown by colors. The regions corresponding to P40 and P90 are also shown in MPN142. c Scheme of native P1 and P40/P90 proteins and the
recombinant constructs used for crystallization and cryo-EM analysis. The major cytoadherence epitope of P1 reported previously is indicated (1383–1395).
The boundary between P40 and P90N proteins identified in this study (445 R/A) is indicated by arrows (Supplementary Fig. 5). Positions of 6 × His-tag
used for purification of recombinants are shown by red boxes.
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pneumoniae to cells of the respiratory tract is mediated by a
network of adhesins and cytoadherence accessory proteins9,10.
Within this network the 170 kDa protein P1 was identified as a
major determinant for cytoadherence and gliding motility with
antibodies against P1 preventing both adhesion and motility9–12.
For about 40 years, P1 has been assumed to be responsible for
binding to sialic acid oligosaccharide receptors from the host
cells13. Because all these relevant properties, P1 has been
attracting attention since the late 1970s, although it was soon
recognized that accessory proteins were also required for its
functioning14. P1, together with the P40/P90 polypeptides, forms
a transmembrane complex called the “Nap”15,16. The structure of
the Nap complex of M. genitalium, a human urogenital pathogen
closely related to M. pneumoniae, was recently revealed by single-
particle cryo-electron microscopy (cryo-EM) at 9 Å and cryo-
electron tomography (cryo-ET) at ∼15 Å resolution17. The M.
genitalium Nap structure consists of a dimer of a P140–P110
complex protruding outward from the mycoplasma membrane
and forming a large knob with a diameter of ∼15 nm. P140 and
P110 are the M. genitalium orthologues of P1 and P40/P90,
respectively. Therefore, it was most unexpected to find that in M.
genitalium the binding site for sialic acid oligosaccharides is in
P110 and not in P14017,18. P1 is considered to be one of the most
immunodominant proteins in M. pneumoniae cells, playing a
major role in the immune response of infected patients and
accordingly in diagnosis and epidemiologic studies3,19,20. The M.
pneumoniae genome contains repeated regions, denominated
RepMPs. The majority (75%) of RepMPs has homology with
MPN141 (P1) and MPN142 (P40/P90) (Fig. 1b). Homologous
recombination between RepMPs and either MPN141 or MPN142
generate variability within antigenic regions of P1 and P40/P90,
respectively, providing an essential strategy to evade the immune
host system21–23. P40/P90 consists of two polypeptides from the
proteolytic cleavage of a 130 kDa translate encoded by MPN14224
(Fig. 1b). Historically little attention has been dedicated to P40/
P90 and the contribution of P40/P90 to cytoadherence is much
less studied than for P1. Even the presence of the P40 polypeptide
in the Nap has been questioned and the reason for and
mechanism of the MPN142 cleavage remain unknown25.
In the present work, we report the structures of M. pneumoniae
proteins P1 and P40/P90 and of complexes of P40/P90 bound to
sialylated oligosaccharides. The results elucidate the antigenic
organization of these immunodominant proteins allowing the
mapping of the genetic and clinical variability. Moreover, ser-
ological tests on different fragments of P1 reveal the recognition
preference of IgG antibodies for conserved over variables regions,
suggesting an immune system strategy of selecting these regions for
long-term immunity. The information is considered pivotal for
clarifying the motility, infectivity, and epidemics ofM. pneumoniae.
Results
Structure determination of P1. Crystals were obtained of the M.
pneumoniae Nap protein P1 extracellular region (residues Thr29-
Asp1521). This P1 construct, empirically chosen after many crys-
tallization attempts, excludes the predicted N-end of the signal
secretion peptide (spanning residue Met1 to Leu59 according to the
structural properties prediction program Psipred26). In this con-
struct are also excluded the (predicted) transmembrane and intra-
cellular regions at the C-end of P1 (residues Tyr1522 to Ala1627)
(Fig. 1c). These P1 crystals were solved simultaneously with the
determination of the crystal structure from the M. genitalium
orthologous protein P140, by averaging between crystals from both
proteins (with 41% sequence identity) despite neither molecular
models nor experimental phases were available (see “Methods”)
(Supplementary Fig. 1). The final refined model of P1, at 1.9 Å
resolution, has agreement R and Rfree factors of 18.7 and 22.9,
respectively (Fig. 2a, b and Supplementary Table 1).
The structure of the ectodomain from P1 was also studied by
single-particle analysis using cryo-EM (Figs. 1c and 2b and
Supplementary Fig. 2). Although P1 particles were clearly
observed in the cryo-EM micrographs, the quality of the map
was too poor to refine the atomic model owing to severe
orientation bias. To alleviate this problem, we collected data by
using grids covered with a thin film of graphene oxide (GO),
which drastically improved the data quality27 (Supplementary
Fig. 2a). A total of 68,014 selected particles yielded a 3D EM map
at an overall resolution of ∼2.9 Å, according to the gold-standard
Fourier shell correlation (FSC) 0.143 criterion (see “Methods”)
(Supplementary Table 2).
The structure of P1 consists of a large N-terminal domain, with
Asn60 as the first residue visible in the X-ray and the cryo-EM
maps, and a smaller C-terminal domain (residues Gly1395–
Asp1521) (Fig. 2). The N-terminal domain of P1 has a β-sheet
propeller topology of seven consecutive blades or β-sheets, each
with four antiparallel strands, except for β-sheet VII that contains
only two strands. Interestingly, these two strands correspond
exactly to a peptide with important immune properties, which
had been defined as the cytoadherence epitope28 (Fig. 2c). The
lengths of connections between the β-sheets of the propeller are
very diverse, ranging from just seven residues between sheets VI
and VII, to 315 residues between sheets IV and V. Links between
adjacent β-strands in the β-sheets of the propeller, also vary
widely in length, ranging from just 11 to 219 residues. The longest
intra and inter β-sheet connections cluster together creating a
crown-like structure on one side of the β-propeller opposite to the
position where the C-terminal domain is located. In the crown
there are 13 disordered loops, spanning 117 residues, which could
not be built (Fig. 2c). These disordered regions, essentially the
same in the X-ray and cryo-EM structures, are spread over the N-
terminal domain surface (Supplementary Figs. 1 and 3a).
Therefore, the N-terminal domain of P1 can be described as a
structured core surrounded by a fuzzy surface. The C-terminal
domain contains only one disordered loop (residues Thr1483–
Asn1495) and has an elongated fold with the same unique
topology (according to DALI29) as the C-terminal domain of
adhesin P110 from M. genitalium.
The cryo-EM and X-ray maps of P1 are well defined for most
of the N-terminal domain with the residues clearly identifiable, in
general, in both maps (Fig. 2b). However, from residue Pro1388
to the C-end, a region that includes the hinge between domains
and the whole C-terminal domain, the density in the cryo-EM
map becomes weak, indicating that there are hinge-like move-
ments between domains. In the crystal structure, the C-terminal
domain is anchored by crystal contacts and the density is clear
and crisp, while in the top part of the crown, with few crystal
contacts, temperature factors are high (Supplementary Fig. 3b)
and chain tracing was difficult. Together the cryo-EM and X-ray
maps provide accurate structural information about the whole P1
ectodomain, proving the mobility of domains with respect to one
another and confirming the characteristic presence of a large
number of disordered loops.
Crystal structure of P40/P90N. Diffracting crystals could not be
obtained with constructs of the complete extracellular region of
P40/P90, which is predicted by Psipred26 to span from Ala25 to
Pro1113 (with Met1 to Leu24 corresponding to a signal N-pep-
tide) (Fig. 1c). After numerous attempts, high-resolution dif-
fracting crystals were grown from a construct, referred henceforth
as P40/P90N, spanning residues Ser23-Val1003 that, by sequence
alignment, corresponds to the N-terminal domain of the M.
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genitalium orthologous protein P110 (Supplementary Fig. 4). The
P40/P90N crystals, with two subunits in the asymmetric unit,
were solved by molecular replacement using as a searching model
the structure of P110 (PDB entry 6R3T), with a sequence identity
between the extracellular regions of 44%. The refined P40/P90N
structure, at 2.65 Å resolution, has agreement R and Rfree factors
of 21.4 and 23.4, respectively (Supplementary Table 1).
The structure of P40/P90N reveals a large globular domain that
is structurally closely related to the N-terminal domain of P110,
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Fig. 2 X-ray and cryo-EM structures of P1. a Ribbon representation, with three 90° apart views, of the complete extracellular region of P1. The large N-
terminal domain is organized around a seven-blade β-propeller (light orange) from where the crown (green) emerges. The C-terminal domain (cyan) is
immediately followed by a predicted transmembrane helix, which requires the proximity of this domain to the cell membrane. b P1 map densities from cryo-
EM (left panels) and X-ray crystallography (right panels). Insets show representative regions from the N-terminal domain (top) and the C-terminal domain
(bottom). The quality of the cryo-EM density provides the clear identification of residues in the N-terminal domain (at an estimated resolution of 2.9 Å).
On the contrary, the C-terminal domain is poorly defined in the cryo-EM map, indicating high flexibility with respect to the N-terminal domain. The core of
the N-terminal domain and, especially, the C-terminal domain are well defined in the X-ray map, while the very top of the N-terminal domain presents high-
temperature factors and was difficult to trace. c Topology of the β-propeller in P1. Loops contributing to the crown are colored green. Disordered loops are
indicated with black dots and the stretch of serines (the AGT repeats) with a red cross. Strands and loops are not in scale.
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Fig. 3 X-ray structure of P40/P90 and of its complex with oligosaccharide 3SL. a Ribbon representation, with three 90° apart views, of the crystal
structure from the P40/P90 N-terminal domain that is organized, similarly to P1, around a seven-blade β-propeller (light orange) from where it emerges
the crown (pink). The sialic binding site found in P40/P90 is explicitly indicated. The predicted C-terminal domain of P40/P90 is also shown (cyan),
modeled from the C-terminal domain of the orthologous adhesin P110 from M. genitalium. b Topology of the β-propeller from P40/P90. Loops contributing
to the crown are colored pink. The first blade β-sheet contains only three strands in P40/P90 placing the N-end at the propeller face opposite to the one in
P1. Localizations of the disordered loops and sialic binding site are indicated with black dots (black) and a star (blue), respectively. The position of the
cleavage site, which results in the corresponding P40 and P90 separate polypeptides, is depicted with a pentagram (pale blue). Strands and loops are not in
scale. c Binding of 3SL to the N-terminal domain of P40/P90. Ribbon representation of the P40/P90N structure in complex with oligosaccharide 3SL. The
inset shows a detail of the residues shaping the binding pocket. The electron density omit map (at 0.9 sigma) corresponding to 3SL is also shown.
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Supplementary Fig. 4). The sequence of P40/P90N presents two
long insertions with respect to P110 of more than 60 residues
each (Gly297–Thr368 and Leu395–Thr462 that are referred as S1
and S2, respectively) (Fig. 3b and Supplementary Fig. 4). Both
insertions, completely disordered in the crystal structures
determined, are found between β-propeller blades II and III.
P40/P90, like P1, has a seven-blade β-propeller topology with
many of the connections between the β-strands clustering
together and forming the crown (Fig. 3b).
P40 and P90 had often been considered as two independent
proteins resulting from the posttranslational processing of the
MPN142 gene product25,30. In our hands, the purified P40/
P90 samples present a characteristic SDS-PAGE gel pattern
indicating a slow progression of cleavage in a few specific locations
(Supplementary Fig. 5a). The primary scission occurs between
Arg445 and Ala446, located toward the C-end of insertion S2
(Fig. 3b and Supplementary Figs. 4 and 5a). The two polypeptides
produced by this primary cleavage, the shorter spanning from the
N-end to Arg445 and the longer from Ala446 to the C-end, can
correspond to the subunits P40 and P90 that are found in
mycoplasma cells30. When the primary scission site was mutated to
avoid cleavage, the P40/P90 variant protein (Ser445–Ser446)
presented, unexpectedly, a similar proteolysis pattern with cleavage
taking place between Arg455 and Ala456, still in the S2 insertion
(Supplementary Fig. 5a). Studies with mycoplasma cells had
reported two cleavage sites occurring between Arg445–Ala44630
and (probably) Leu454–Arg45525,31, in good agreement with the
two cleavage Arg–Ala sites (RA motifs) now found in vitro.
Regardless of the extend of proteolysis, all P40/P90N samples
behave as a single and sharp peak by SEC–MALS (Supplementary
Fig. 5b) indicating that cleavage takes place only when folding is
completed and that a unique three-dimensional structure of P40/
P90N is maintained. Structural stability of the cleaved protein
probably relies on the large interface between the P40 and P90
polypeptides, with 75 hydrogen bonds, 6 salt bridges, and a buried
surface area of 10,480 Å2, which gives an estimated free energy of
−55 kcal with an expected 100% probability of formation
according to the Complexation Significance Score algorithm in
PISA32 (Supplementary Fig. 6a). Addition of EDTA to the P40/
P90 samples halts proteolysis completely, which suggests a key role
for divalent metals. No metals were found in the crystal structures
of P40/P90, but EDTA was required for the crystallization
conditions. The presence of significant amounts of Zn2+ ions in
a purified P40/P90 sample was detected by inductive coupled
plasma–mass spectrometry (ICP–MS), although the concentration
of protein was higher than the one found for the ion (see
“Methods”). The possible presence in the P40/P90 samples of an
undetected protease, which could be coming from the over-
expression in Escherichia coli, was analyzed by SEC–MALS.
Different constructs of P40/P90N, with and without the C-
terminal domain, always produced a sharp peak at the molecular
weight corresponding to the construct, without any indication of
other species. Altogether these results suggest that cleavage of P40/
P90 is a self-proteolytic process. However, we have not yet been
able to find the residues that could be responsible for this
enzymatic activity. Besides insertions S1 and S2, the structure of
P40/P90 presents only three short disordered loops (residues
Ser118–Gly127, Ser168–Gly175, and Ala774–Arg777) and the N-
terminal domain from P40/P90 can be seen as a well-defined
globular structure with two long floppy pendants (Supplementary
Fig. 3a). The complete extracellular region of P40/P90 was
generated by combining the structure of the N-terminal domain
with the structure of the Pro1004–Pro1113 region of P40/P90
modeled according to the P110 C-terminal domain because the
sequence identity is high (68%) and the expected RMSD low (∼0.6
Å)33 (Fig. 3a and Supplementary Fig. 4). In solution, P1 and P40/
P90 form an heterodimer showing a single peak in a gel filtration
profile (Supplementary Fig. 5c).
Complexes of P40/P90N with sialylated oligosaccharides. The
presence of a sialic binding site in P40/P90 was confirmed by the
crystal structures of complexes of P40/P90N with oligosacchar-
ides 3SL (neuraminic acid forming an α2–3 linkage to a lactose
monosaccharide) and 6SL (with an α2–6 linkage) (Supplementary
Table 1). This result is consistent with the facts that sialylated
oligosaccharides act as cell receptors for M. pneumoniae and M.
genitalium34–36, and that adhesin P110 from M. genitalium, the
orthologue of P40/P90 contains a binding site specific for neur-
aminic acid18. The sialic binding site of P40/P90 is in a location
structurally equivalent to the one in P110, in the upper part of the
crown (Fig. 3a, c and Supplementary Fig. 7). Only the neuraminic
acid moiety interacts directly with the P40/P90 β-hairpin that
contains the X-Tyr/Phe–Ser/Thr motif (Leu630–Phe631–Thr632)
characteristic for the binding to sialic compounds18,34. P40
functions as the external rim of the sialic binding site pocket,
which would become exposed without P40 (Supplementary
Fig. 6b). Surface plasmon resonance (SPR) indicates that sialy-
lated oligosaccharides bind to P40/P90 with dissociation con-
stants (Kd) in the micromolar range for 3SL (∼8.0) and 6SL
(∼2.9), similar to the values reported for P11018 (Supplementary
Fig. 8) although, according to in vivo studies, 6SL binds at a much
lower affinity than 3SL37,38. For P1, SPR shows no binding to
sialylated oligosaccharides, in agreement with what is observed
for M. genitalium17.
Structural relationships of P1 and P40/P90. The structural
results reveal that P1 (1627 residues) and P40/P90 (1218 residues)
present a similar overall organization and topology in the extra-
cellular regions. The similarity is maintained between the trans-
membrane helices and the cytoplasmic regions where the
sequence identity of P1 and P40/P90 is high (43%). Despite the
different size, the close relationship of both proteins suggests that
P1 and P40/P90 have a recent common phylogenetic ancestor.
Superposition of N-terminal domains from P1 and P40/P90, with
a sequence identity of only 12%, gives a RMSD of 3.5 Å for 361
equivalent residues, which correspond mainly to residues from
the β-sheets of the propellers. However, β-sheet I has only three
strands in P40/P90, but four in P1 and this “extra” first strand in
the first β-sheet of P1 places the N-end in the propeller face that is
the opposite to the one in P40/P90 (Fig. 4). The “extra” first
strand of β-sheet I from P1 starts with a large β-bulge (residues
69–77) occluding the center of the propeller, contrary to P40/P90
where the center is empty. Linkage between the N- and C-
terminal domains of P1 changes with respect to P40/P90, due to
the absence of the last two strands in β-sheet VII. Therefore, β-
sheets I and VII, structurally contiguous within the propeller,
present the largest differences between P1 and P40/P90. The
hypothesis of a recent common origin is further supported by the
close structural relationships between the C-terminal domains
from the non-orthologous proteins P1 and P110, with a sequence
identity of 19% and a RMSD of 2.0 Å for 73 equivalent residues
(Supplementary Fig. 9a), The hypothesis is also reinforced by the
presence of the characteristic “AGT repeats” motif in the same
loop of the propellers, between the second and third β-strands of
the fourth blade, of P1 and P110 (Supplementary Fig. 9b).
Mapping of epitopes and genetic variability onto P1 and P40/
P90. Epitopes reported for six monoclonal antibodies (mAbs)
against P1 with inhibiting cytoadherence activities for M. pneu-
moniae (aN, P1.62, P1.26, M51, M58, and 6E7)28,39 (Supple-
mentary Fig. 10) are all exposed on the surface of P1, as expected
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to be accessible by the antibodies (Fig. 5a). Epitopes from mAbs
aN, P1.62, P1.26, and 6E7 are located in the N-terminal domain,
whereas epitopes from mAbs M51 and M58 are in the C-terminal
domain. The epitope from mAb 6E7 corresponds to the strands
from the last β-sheet of the β-propeller, close to the C-terminal
domain. The mAbs, P1.62 and P1.26 are reported to bind to dual
epitopes (Supplementary Fig. 10), separated on the structure of
P1 (Fig. 5a). Although dual epitopes of P1.26 are both exposed in
the structure of P1, one of them positioned on Asn980–Lys987
might become hidden in the Nap complex.
Two other reported epitopes (Trp810–Tyr817 and Phe1124–
Arg1131), recognized by sera from many of the M. pneumoniae
infected patients20, are located in the N-terminal domain (Fig. 5a).
The first of these exist inside the P1 molecule, while the second is
exposed in the P1 surface, although its accessibility might also be
limited in the Nap complex. These two epitopes might be
immunodominant for antibody production; however, antibodies
against these epitopes may not have cytoadherence-inhibitory
activities.
Sequences of P1 and P40/90 exhibit sequence variations
depending on the M. pneumoniae strain. The two major variation
types, known as 1 and 2, are harbored in strains M129 and FH,
respectively22,31,40. For P1 the main source of variability is
RepMP4 and RepMP2/3, while for P40/P90 is RepMP541. It has
been reported that mAb P1.62 only binds to type 2 P1 protein42,
consistent with the fact that the epitope of this mAb is located at a
variable site. The structures of P1 and P40/P90 served as a
topographic map to determine positions of known variable
regions. RepMPs from P1 and P40/P90 are exclusively located at
the N-terminal domains of these proteins, with the C-terminal
domains remaining genetically conserved (Fig. 5b, c).
Polyclonal antibodies against constructs of the C-terminal
domain. Adherence-inhibiting antibodies recognizing the con-
stant C-terminal domain of P1 could be more effective in eliciting
immunoprotection than antibodies to variable regions within the
N-terminal domain. Previous studies had shown that gliding and
binding of M. pneumoniae were affected by addition of a
monoclonal antibody generated against a large recombinant
fragment of P1 (residues Ala1160–Gln1518) that contains the C-
terminal domain12. To consolidate these results and to better
delineate the binding site of antibodies during an immune
response, polyclonal antibodies were generated against two con-
structs of P1 spanning residues Lys1376–Asp1521 and
Ala1400–Asp1521 (see “Methods”). The shortest construct cor-
responds accurately to the C-terminal domain, while the longest
construct also includes the hinge between domains and the two
strands from blade VII (Fig. 6a). Quantitative PCR (qPCR) was
used to measure the amount of genomic DNA (gDNA) from the
M. pneumoniae cells in solution, the fraction not adhered to the
glass (see “Methods”). The M. pneumoniae cells had been pre-
viously incubated with different percentages of sera from rats
challenged with the P1 constructs. The analysis determines how
much the M. pneumoniae cells are affected by the presence of the
polyclonal antibodies. Without exposure to sera, 81% of the M.
pneumoniae cells attached to the plastic surface upon incubation
of these (scraped) cells for 2 h in 24-well plates. Then, to evaluate
the possible toxicity by other components of the sera, such as the
complement that enhances the ability of antibodies and phago-
cytic cells to clear microbes, different percentages (1, 3, 6, and
10%) of serum obtained from pre-immune bleed (PPI) of chal-
lenged animals were tested. The total number of recovered
mycoplasma after incubation only decreased with the highest
concentrations (6 and 10%) of PPI when compared with samples
not treated with serum (Supplementary Fig. 11a). Thus the low
concentrations (1 and 3%) were selected to test the inhibitory
effects on the adhesion capability of M. pneumoniae cells
(Fig. 6b). Toxicity effects can be subtracted, at least in part, by
normalization with the corresponding values of PPI serum and
the measures for concentrations of 10% are also reported (Sup-
plementary Fig. 11b). As a final checking, the specificity of anti-
bodies for the C-terminal constructs was also assessed. Serum
from challenged rats presented no significant differences with
their PPI when incubated with the corresponding constructs
before the quantitative adhesion assay.
Incubation of serum from rats challenged with the longest C-
terminal domain construct resulted in the number of the M.
pneumoniae cells attached being decreased significantly with
reduction ratios with respect to PPI samples of 0.31 and 0.56 for
added serum concentrations of 1% and 3%, respectively (p values
of 9 × 10−6 and 1 × 10−6 by applying t-test one-tailed distribu-
tion; two samples equal variance). Reduction ratios for the short
construct were 0.22 and 0.33, for added serum concentrations of
1% and 3%, respectively (p values of 0.016 and 3 × 10−4).
Together these results reveal that M. pneumoniae adhesion
capabilities are significantly reduced by polyclonal antibodies
generated against C-terminal domain constructs of P1, with
























































Fig. 4 Comparison of P1 and P40/P90. Comparison of the β-propeller
structures and of their connections with the corresponding C-terminal
domains in P1 (left panels) and P40/P90 (right panels). The C-terminal
domain is tangential to the propeller ring in P1 and protrudes radially in
P40/P90, where the C-terminal domain was modeled from the orthologous
adhesin P110 from M. genitalium. The N-ends are situated in opposite faces
of the propeller in P1 and P40/P90. The center of the propeller is occluded
in P1 but empty in P40/P90.
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Fig. 5 Mapping of P1 epitopes. Variability in P1 and P40/P90. a Mapping into the P1 structure of all known epitopes (Supplementary Fig. 10). Most
epitopes are located on the protein surface, although accessibility by antibodies appears to be difficult for a few of them. b Three views of the P1 surface,
90° apart from each other, with the genetically variable regions (brown), RepMP4 (light pink), RepMP2/3 (light blue), and the C-terminal domain (cyan).
c The corresponding three views of the P40/P90 surface, with the genetically variable regions (brown), RepMP5 (green), and the C-terminal domain
(cyan). The C-terminal domain, modeled from the structure of P110, is depicted as ribbons. Sites of genetic and clinical variability are also represented for
P1 and P40/P90 in the lower part of the corresponding panels. Clinical variability refers to the variation exhibit by clinical isolates characterized so far. In
turn, “genetic variability” indicates regions that are potentially variable by DNA recombination between RepMP elements in M. pneumoniae genome.
Presently, genetic variability regions are wider than clinical variability.
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Recognition of P1 and P40/P90 by sera from M. pneumoniae
patients. Determination of the structural organization from the P1
and P40/P90 ectodomains encouraged us to assess the immuno-
genic activity of different constructs from these proteins using total
sera from 19 patients with positive diagnostic for M. pneumoniae
based on serological tests (Table 1). Clinically relevant information,
including the IgG and IgM values, was available for all sera. In
addition, sera from five patients that tested negative for M. pneu-
moniae were also included in the study for control purposes. First,
the immunodominant nature of the adhesins was confirmed,
revealing that 17 out of the 19 sera (90%) tested positive for P1.
Similarly, 14 sera (74%) tested positive for P40/P90; all positive sera
for P40/P90 were positive for P1. Of note, eight sera (42%) were
also positive for P140. This result is not unexpected because P1 and
P140 show extensive antibody cross-reactivity43. Alternatively,
some of the P140 positive patients might have been infected with
M. genitalium in addition to M. pneumoniae. Next, the sera
response was examined with the same two C-terminal domain
constructs of P1 (Lys1376–Asp1521 and Ala1400–Asp1521)
described before in the generation of polyclonal antibodies. The
number of positive sera, 5 out of 19 (26%), decreased substantially
with respect to the full length P1, although importantly all these
positive sera correspond to the ones with highest IgG levels.
For P40/P90, an additional evaluation of the sera reactivity
with recombinant proteins lacking either insertion 1 (S1), or
insertions 1 and 2 (S1S2) was performed to assess the
contribution of the insertions and the loss of the proteolytic site.
Construct S1 was detected by 14 out of 19 sera (74%), the same
ratio to that of the entire P40/P90. In contrast, remarkably, there
is an important decrease to just seven positive sera (37%) when
the P40/P90 S1S2 construct was evaluated. Furthermore, even for
most of these seven positive sera the response was substantially
reduced. Therefore, results indicate that P40/P90 is a strong
immunogenic protein, with insertion 2 (S2) acting as an
immunodominant region, although recognized by sera with low
IgG levels.
Discussion
Adherence of M. pneumoniae to sialylated receptors on the sur-
face of respiratory cells was elucidated years ago34,35,37,44. Since
the identification of the critical role of P1 in M. pneumoniae
cytoadherence, it has been accepted that this protein was
responsible for binding to sialic acid oligosaccharides11–14,45. In
addition to P1, other cytadherence-accessory proteins had been
reported as required for binding to sialic acids14,46. The present






































Fig. 6 Inhibition adhesion assays of polyclonal antibodies generated against constructs of the P1 C-terminal domain. a Residues corresponding to the P1
constructs used as antigens to generate polyclonal antibodies are colored in cyan in the structure of P1. The short construct (left, residues
Ala1400–Asp1521) includes only the C-terminal domain. The long construct (right, residues Lys1376–Asp1521) includes also the hinge, which connects the
N-terminal domain with the C-terminal domain, and the two strands from the last propeller β-sheet, also known as the cytoadherence epitope. b Sera
raised against any of the two constructs inhibit adhesion of M. pneumoniae cells even at low concentrations, with 3% showing a significantly higher
inhibition than 1%. Error bars represent the mean ± standard deviation. *p < 0.05 and ***p < 0.001. Source data are provided as a Source Data file.
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study demonstrates that the binding in vitro to sialic acid
receptors relies in fact on P40/P90 (Fig. 3c and Supplementary
Fig. 7), however, affinities and specificities could be tuned
through other proteins or due to the density and distribution of
the oligosaccharides in the surface37,38. This important result is
consistent with the recent finding that binding to sialic acid oli-
gosaccharides is mediated by P110 in M. genitalium18. Cleavage
of the P40/P90 polypeptide chain occurs in vitro at two exposed
Arg–Ala motives (Arg445–Ala446 and Arg455–Ala456) located
in the central part of the N-terminal domain, producing two
polypeptide chains that can correspond to the P40 and
P90 subunits found in vivo (Supplementary Figs. 4 and 5a).
Cleavage appears to be a divalent metal ion dependent auto-
proteolysis taking place only after the folding is completed.
Nevertheless, P40/P90 continues to behave as a single globular
protein structurally similar to P110. This is in agreement with the
extensive interface between the P40 and P90 polypeptides indi-
cating that they form a very stable ensemble (according to
PISA32) (Supplementary Fig. 6). However, P40 is located at the
outer surface part of the Nap and due to the absence of covalent
bonds might become separated from P90 and from the Nap
complex under stringent or denaturing conditions. The loss of
P40 only in certain conditions could explain the discrepancies in
the past about whether or not P40 was part of the adhesion
complex. The sialic acid oligosaccharides binding site is located in
a loop of the P90 polypeptide with P40 contributing only to the
entrance of the pocket (Fig. 3c and Supplementary Fig. 6).
There are clear structural relationships between P1 and P40/
P90 suggesting a common protein ancestor, a hypothesis that is
reinforced by the structural similarities found between P1 with
the non-orthologous protein P110 fromM. genitalium (Fig. 4 and
Supplementary Fig. 9). This common ancestor could have been
encoded in a mobile element, thus facilitating transmission within
different species of the pneumoniae cluster. The presence of
multiple copies of the adhesin genes in the genomes of several
mycoplasmas supports this hypothesis. In each species, the
adhesin genes may have evolved to mediate adherence to different
hosts and tissues. Molecular systems where one of the catalytic
sites, at the interface of two paralogs, is lost during evolution can
be related with the situation in F-type ATPase/synthase, widely
distributed among most living organisms47, raising the possibility
of a similar evolutionary process for the Nap. Interestingly, the
sequence identity between P40/P90 and P1 is low in the N-
terminal domains (12%), increases in the C-terminal domains
(17%), and becomes high for the transmembrane and cytoplasmic
regions (43%). The increased variation of the sequences from the
most exposed regions of the Nap, the N-terminal domains, can
reflect specific attachment and motility requirements but also a
mycoplasma survival strategy related with enhanced antigenic
variability.
To date, 13 antigenic variants have been identified in clinical
isolates for P1 and 5 for P40/P9048 (Fig. 5b, c). Regions of P1 and
P40/P90 presenting genetic and clinical variability cluster at the
surface of the upper part of the N-terminal domain, where
antibodies could easily block access to the receptor binding site.
In fact, mapping the known genetic variability of M. pneumoniae
onto the Nap structure, modeled according to the information
available from M. genitalium with the structures of P1 and P40/
P90, reveals that the sialic binding site pocket is completely
surrounded by these variable regions (Fig. 7). P1 and P40/P90
present many sequence insertions, which amount to more than
200 extra residues in each protein, with respect to their ortho-
logues P140 and P110 in M. genitalium (Supplementary Figs. 1
and 4). Interestingly, most of the insertions correspond to dis-
ordered regions in the structures of the M. pneumoniae proteins.
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RepMP4 RepMP2/3 RepMP5 Genetic variation AGT repeat
90°
90°
Fig. 7 Structure of the M. pneumoniae Nap. a Representation of the whole M. pneumoniae Nap ectodomain as a dimer of a P1-P40/P90 heterodimer,
modeled from the information recently available for M. genitalium. Binding to a receptor from the host cell, a human alveolar epithelial cell, is indicated. The
sialic acid binding site is located in a pocket at the top of the Nap that is not far from the twofold symmetry axis of the Nap. The crowns from P1 (green)
and P40/P90 (pink) are separated by the β-propellers (brown) from the C-terminal domains (cyan), which anchor the Nap to the mycoplasma membrane.
b Three views, 90° apart from each other, of the Nap surface depicting the sialic acid compound 3SL (spheres) bound into the binding site of the two P40/
P90 subunits of a Nap. Regions with genetic variability of P1 and P40/P90 (brown) cover most of the surface from the upper part of the Nap. RepMP5 from
P40P90 is depicted in green, while RepMP4 and RepMP2/3 from P1 are depicted in pink and blue, respectively. C-terminal domains from both P1 and P40/
P90 are depicted in cyan. The inset shows the sialic binding site pocket, with a 3SL molecule bound, surrounded by genetically variable regions.
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but 2 of them more than 60 residues long (insertions S1 and S2).
The C-terminal domain from P1 contains only one disordered
loop and no genetic variability, pointing to the interest of
immunogenic studies with this domain.
Polyclonal antibodies against two constructs from the C-
terminal domain of P1 (Lys1376–Asp1521 and
Ala1400–Asp1521) inhibit the cytoadherence of M. pneumo-
niae cells (Fig. 6b). In addition, most of the sera from M.
pneumoniae infected patients presenting a high IgG content
also recognize these C-terminal domain constructs (Table 1).
On the contrary, these C-terminal domain constructs were
poorly recognized by sera from the early stages of infection
where a high IgM content is present. The full length extra-
cellular region of P1 was strongly recognized by all sera,
independently of the IgG or IgM ratios, confirming the
immunodominance of P119. These results indicate that the C-
terminal domain might be a relatively weak or poorly accessible
antigenic region, in agreement with what the structural infor-
mation suggests, but effective to generate more specific IgGs
antibodies capable of inhibiting mycoplasma cytoadherence.
Large P1 constructs, such as the whole extracellular region49 or
a long commercial peptide (residues 1160–1521, LIAISON M.
pneumoniae IgM and IgG, Biotrin International Ltd), maybe
better suited for diagnosis than small C-terminal domain con-
structs, which might, however, provide a significant protective
response. P40/P90, often overlooked in immunological studies
in spite of pioneering studies showing P90 was an important
immunogen50, is recognized by 74% of the sera from infected
patients. Interestingly, the serologic response decreased sharply
for P40/P90 constructs when the second insertion (S2 residues
Leu395–Thr462) was eliminated. Most of the sera that recog-
nize S2 have a high IgM content, dominant in the initial stages
of the immune response. S2 presents the highest genomic (64%)
and clinical (∼80%) variability and is highly exposed and
mobile on the surface of P40/P90. Exposure of S2 is likely
increased by the cleavage at its C-end that generates the two
polypeptides P40 and P90. Altogether these results suggest that
S2, located within P40, might be acting as a decoy to divert the
immune response (Table 1). The high immune response against
P40/P90, with unique structural peculiarities, invites a recon-
sideration of its therapeutic possibilities.
Gliding of mycoplasmas from the pneumoniae cluster,
including M. pneumoniae and M. genitalium, is thought to be
caused by a mechanism where the force, generated by ATP
energy51, is transmitted to the Nap that appears to work as a leg/
foot on the surface of the mycoplasma cell7,8,12,52–56. Gliding of
M. pneumoniae cells is always in the direction of the attachment
organelle, which indicates that the gliding machinery, including
the Naps at the cell surface, should provide a well-defined
directionality. To achieve a directional gliding, the release of the
sialylated receptors is as essential as the binding because myco-
plasma cells cannot move forward if they remain anchored to the
surface receptors where they have first attached. In the Nap, the
conformational changes required by the foot/leg activity during
gliding have to be synchronized with the binding/release to the
cell receptors, which are thought to be randomly distributed on
the host surface. The binding site in P40/P90 could be regulated
by the interaction with P1 as found in M. genitalium17. This may
be the reason why P1 was expected to contain the binding site. In
the cryo-EM map of P1, the weak density of the C-terminal
domain indicates flexibility with respect to the N-terminal
domain proving that P1 can experience significant conforma-
tional changes consistent with the observations that antibodies
that bind to the C-terminal domain can interfere with the
attachment and gliding of mycoplasma cells. Therefore, although
P40/P90 contains the binding site to the sialic acid cell receptors,
P1 has still to be seen as a major player in the Nap functioning
during gliding and also in the adhesion to host cells. Moreover,
proteins others than the Nap components, including P30, P65,
HMW1, HMW2, or PrpC/PrkC, are known to be essential for
binding and gliding57–60. These proteins might support func-
tioning and conformation of the Naps to play its roles.
Integration of previous knowledge with the structural data
obtained in this work provides important clues for a better
understanding of the functioning of Naps in M. pneumoniae,
although many questions remain open about the adhesion and
gliding motility mechanisms. The structural framework obtained
in this work also allows the mapping of epitopes and of the
genetic and clinical variability of P1 and P40/P90 explaining
many of the immunogenic properties of these immunodominant
proteins in M. pneumoniae. These results can help in the devel-
opment of vaccines and therapeutics for inhibiting the infectivity
of this respiratory pathogen.
Methods
Cloning, expression, and purification of P1 and P40/P90 constructs. Regions
corresponding to the MPN141 and MPN142 genes from M. pneumoniae were
amplified from synthetic clones (Supplementary Tables 3 and 4), using primers P1F
and P1R and P40/P90F and P40/P90R, respectively (Supplementary Table 5). The
PCR fragments were cloned into the expression vector pOPINE61 (gift from Ray
Owens plasmid #26043, Addgene, Watertown, USA) to generate constructs, with a
C-terminal His-tag, comprising residues 29–1521 for P1 and 23–1003 and 23–1114
for a short and a long construct of P40/P90, respectively. Recombinant proteins
were obtained after expression at 22 °C in B834 (DE3) cells (Merck), upon
induction with 0.8 mM IPTG at 0.6 OD600. Cells were harvested and lysed by
sonication in 1xPBS, 40 mM imidazole and centrifuged at 49,000 × g at 4 °C.
Supernatant was loaded into a HisTrap 5 ml column (GE Healthcare) pre-
equilibrated in 1xPBS with 40 mM imidazole as binding buffer and 1xPBS with
400 mM imidazole as elution buffer. Soluble aliquots were pooled and loaded onto
a Superdex 200 GL 10/300 column (GE Healthcare) in buffer consisting of TRIS
20 mM pH 7.4 and 150 mM NaCl. Buffers prepared for P40/P90 purification were
supplemented with 1 mM EDTA to prevent proteolysis. Mutants of P40/P90 were
produced following the same protocol as for the wild type, but using the corre-
sponding primers showed in Supplementary Table 5. Cleavage sites in P40/P90
were determined with N-terminal Edman sequencing of the bands obtained by
SDS-PAGE of purified samples of the P40/P90 constructs (Supplementary Fig. 5a).
Mixtures of P1 with either the short or the long P40/P90 constructs were used for
the preparation of complexes in a 1:1 ratio. The presence of stable P1-P40/P90
heterodimers, verified by gel filtration, was the only complex detected in the
mixtures (Supplementary Fig. 5c).
For cryo-EM data collection, P1 of M. pneumoniae M129 strain (MPN141) was
expressed and purified as described previously62. The p1 gene corresponding to the
amino acid residues 60–1518 of P1 adhesin was codon-optimized, synthesized, and
inserted between NdeI and XbaI sites in pCold I vector (TAKARA BIO, Shiga,
JAPAN). The resulting plasmid, pP1-1, wherein p1 was fused to an N-terminal 6 ×
His-tag and a Factor Xa site. BL21 or BL21 (DE3) pLysS cells carrying pP1-1 were
cultured at 37 °C until the culture density reached an OD600 value of 0.3. The cells
were subjected to cold shock at 15 °C for 30 min, followed by the addition of IPTG
to a final concentration of 1.0 mM, and cultured overnight at 15 °C. The cells were
harvested by centrifugation (4000 × g, 10 min, 4 °C) and washed twice with a TN
buffer comprising 20 mM Tris-HCl and 500 mM NaCl. The suspension was frozen
at −80 °C. The cell pellet was thawed, suspended in a binding buffer (20 mM Tris-
HCl pH 8.0, 500 mM NaCl, 20 mM imidazole) containing 1 mM PMSF. Cells were
then disrupted with a Sonication (NIHONSEIKI, Tokyo, Japan). Unbroken cells
were removed by centrifugation (60,000–140,000 × g, 60 min, 4 °C). The
supernatant was loaded onto a HisTrap HP column (GE Healthcare, Milwaukee,
WI) equilibrated with the binding buffer. The bound proteins were eluted with a
linear gradient of 10–200 mM imidazole in TN buffer. Fractions containing P1
adhesin were dialyzed against a TNG buffer (20 mM Tris-HCl (pH 8.0), 150 mM
NaCl) and loaded onto a HiLoad 16/60 Superdex 200 prep grade column (GE
Healthcare) equilibrated with the TNG buffer at a flow speed of 1 mL/min. The
collected P1 adhesin fractions were combined, dialyzed against 20 mM Tris-HCl
(pH 8.0), and applied to an anion exchanger, Q Sepharose Fast Flow equilibrated
with the buffer, and eluted with a linear gradient of NaCl from 0 to 0.4 M. The
purified protein was concentrated using an Amicon Ultra 30k spin filter (Millipore,
Darmstadt, Germany) if necessary.
Crystallization and X-ray data collection of P1 and P40/P90N. Ninety-six-well
plates crystallization screenings were performed on both Cartesian (Cartesian (TM)
Dispensing Systems) and Phenix (Art Robbins Instruments) robots mixing 150 nL
of reservoir condition with 150 nL of protein solution at concentrations of 6 mg/
mL for each of the P1 and P40/P90 proteins. The optimized crystals of P1 were
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obtained after mixing 1 µL of P1 at 6 mg/mL with 1 µL 20% PEGMME 2000 and
PCB (sodium propionate, sodium cacodylate, and BIS-TRIS propane pH 4) as a
reservoir condition in a ratio of 2:1, respectively. P40/P90N optimized crystals were
obtained mixing 1 µL of P40/P90N at 6 mg/mL with 1 µL 20% PEG 3350, 0.3%
MetOH in a ratio 1:1, respectively. To obtain crystals of P40/P90N in complex with
3SL or 6SL, protein samples were previously incubated with 10 mM of each oli-
gosaccharide 1 h at 20 °C. All attempts for P40/P90 crystallization were not suc-
cessful. Crystals used for data collection were flash frozen in liquid nitrogen with
15% glycerol as cryo-protectant.
X-ray data collection was carried out at Xaloc beamline (ALBA Synchrotron,
Spain). Data were processed with Xia263 using XDS64, Aimless and Pointless65
from the CCP4 suit of programs66.
Determination of the P1 crystal structure. The crystals from P1 belong to space
group C2 and could contain, by packing considerations, only one subunit in the
asymmetric unit. We tried to solve these P1 crystals by heavy atoms and SeMet
derivatives, but finally the resolution was achieved by density modification tech-
niques applying solvent flattening and averaging with crystals from the M. geni-
talium orthologous protein P140, whose structure was also unknown at that time17.
With this procedure the structures of P1 and of P140 (with a sequence identity of
41% between their ectodomains) were solved simultaneously. The P140 containing
crystals used corresponded to crystals from the complex of P140 with the N-
domain of P110 (P140–P110N) and to crystals from P140 alone. Steps followed for
the structure determination of P1 and P140 were the following:
(1) A partial molecular replacement solution was obtained for the P140–P110N
crystals using as searching model the N-domain from the P110 structure17.
This partial solution of the P140–P110N crystals contained four P110N
subunits in the asymmetric unit. The four P110N subunits were organized
as two pairs and within each pair the two subunits were related by accurate
local (non-crystallographic) twofold axis. In this partial solution, no density
was visible that could correspond to P140.
(2) From this partial solution of the P140–P110N crystals, a difference (Fo–Fc)
map was generated at about 3 Å resolution. Positive densities in this
difference map, expected to correspond mainly to P140, were tentatively
reinforced by averaging (without applying any mask) using one of the local
twofold symmetries. This unmasked averaging also weakens density from
other subunits in the crystal not related by the local twofold symmetry. In
this averaged density it was possible to differentiate continuous regions of
strong and of weak density, but it was not yet possible to identify any
consisting molecular feature from P140.
(3) The cryo-electron tomography (CET) map of a whole M. genitalium Nap17
was then used to define an initial possible mask for P140. The CET map, at
∼17 Å resolution, corresponded to a dimer of P140–P110 complexes, where
the fitting of the P110 structures was unambiguous. The CET map was
placed on the (Fo–Fc) averaged map by superposing the corresponding fitted
P110 structures. Then, a putative “P140 initial map” was generated as the
(Fo–Fc) averaged density inside the CET envelop corresponding to P140.
After some polishing (avoiding overlapping with neighbor subunits or
retaining regions with continuous densities) the assumed “P140 initial map”
was used to perform a molecular replacement search (using program
PHASER) obtaining a reasonable possible solution with four P110N
structures and four “P140 initial maps.” Attempts to use the density from
the CET maps directly for phasing, and not just as a mask, were unsuccessful
in our hands.
(4) Iterative cycles of density averaging (and solvent flattening), alternating with
manual readjustments of the P140 mask, were then performed with the
P140–P110N crystals. The procedure converged giving clearer and more
continuous density, although no secondary structures that could correspond
to P140 were visible. Likely, the almost parallel orientation of the two non-
crystallographic twofold axes weakened the phasing power of this averaging.
In spite of the limitations, the new density (within the updated mask)
allowed obtaining a molecular replacement solution for the P1 crystals.
Surprisingly, the new density did not provide a solution for the P140 alone
crystals.
(5) Density modification with averaging within the P140–P110N crystal and
now also with the P1 crystals (using program DMMULTI67) improved
quickly the maps. The iterative cycles of DMMULTI were alternated with
cycles of phase extension for the P1 crystals (using the “autobuild” protocol
in Phenix at 1.94 Å resolution) and with manual readjustments of the
averaging masks (that were updated about forty times). Model building was
carried forward for P1 and P140 in parallel. With about 50% of the
structures traced, it was possible to obtain a molecular replacement solution
for the P140 alone crystals that, with six subunits in the crystal asymmetric
unit, facilitated the completion of the P1 and P140 structures.
P1 was then refined, giving agreement factors R and Rfree of 18.7% and 22.9%,
respectively (Supplementary Table 1). The difference between these two factors was
used traditionally to assess how well the available molecular model explains the
corresponding experimental diffraction data. The difference between both factors is
related with the bias introduced in the model during refinement. Despite the
quality of the final map (Fig. 2b), the P1 structure presented a significant amount of
disordered residues located at the N-end (missing residues 29–59) and in 14 loops
(102–105, 228–230, 259–268, 278–282, 298–300, 337–348, 831–847, 870–888,
923–928, 941–944, 1226–1232, 1308–1324, 1341–1349, and 1482–1495). The final
refined structure has been deposited in the PDB with code 6RC9.
Determination of the P40/P90 structures. The P40/P90 crystals belong to space
group P212121 and contain two subunits in the asymmetric unit. The structure was
solved by molecular replacement with program Phaser68 using as searching model
the structure from the orthologous protein P110 from M. genitalium (PDB code
6R3T). The structure of P40/P90 was refined at 2.65 Å resolution, giving agreement
factors R and Rfree of 21.4% and 23.4%, respectively (Supplementary Table 1).
Crystals of complexes from P40/P90 with 3SL and 6SL belong to space C2,
although with pseudo-orthorhombic unit cell dimensions, and contain one subunit
in the asymmetric unit. The 3SL crystals showed a well-defined oligosaccharide
with high occupancy, at 3.2 Å. The 6SL crystals, at 2.8 Å resolution, presented some
disorder and an overall weak density for the oligosaccharide that was interpreted as
partial occupancy.
Tracing and refinement of all the structures was performed alternating
interactive and automatic cycles with programs Coot69 and Buster70, respectively.
The final refined structures have been deposited in the PDB with codes: 6RJ1 for
P40/P90, 6TLZ for the 3SL complex, and 6TM0 for the 6SL complex.
Single-particle cryo-EM. The purified P1 protein construct was applied onto a
Quantifoil holey carbon grid (R1.2/1.3, Cu, 200 mesh) covered with a thin film of
GO flakes (SIGMA-ALDRICH), blotted for 4.5 s at 4 °C in 100% humidity, and
plunge frozen in liquid ethane by using a Vitrobot Mark IV (Themo Fisher Sci-
entific). Cryo-EM imaging was obtained using a Titan Krios (Themo Fisher Sci-
entific) operating at 300 kV acceleration voltage and equipped with a Cs corrector
(CEOS, GmbH) and a Falcon III direct electron detector (Themo Fisher Scientific).
A total of 5279 movies were obtained in the electron counting mode with a physical
pixel size of 0.69 Å/pixel and total dose of 60 e/Å2 with 36.33 s exposure time. The
data were automatically collected using EPU software with a defocus range of
−0.75 to −2.75 µm and were fractionated into 78 movie frames.
Single-particle cryo-EM image processing. The movie frames were subsequently
aligned to correct for beam-induced movement and drift using MotionCor271, and
contrast transfer function was estimated using Gctf72. A total of 4,574,424 particles
images were automatically picked using Gautomatch (http://www.mrc-lmb.cam.ac.
uk/kzhang/) and several rounds of 2D classification and 3D classification were
performed using RELION-2.173. A total of 295,195 particle images from good 2D
classes were selected for making the initial model of P1 using cryoSPARC74. First
and second 3D classification were calculated with angular sampling interval at 7.5
and 3.7 degrees, respectively. Finally, 68,014 particles from the best 3D class were
3D refined, producing a reconstruction with a resolution of 2.88 Å and a B-factor of
89 Å2 with the gold-standard FSC criteria (FSC ≥ 0.143). The local resolution was
estimated using RELION-2.1. The processing strategy is described in Supplemen-
tary Fig. 2a–d and the model refinement statistics in Supplementary Table 2.
SEC–MALS analysis. The molecular weight of the P40/P90 short construct was
measured using a Superose 6 10/300 GL (GE HEalthcare) column in a Prominence
liquid chromatography system (Shimadzu) connected to a DAWN HELEOS II
multi-angle light scattering (MALS) detector and an Optilab T-REX refractive
index (dRI) detector (Wyatt Technology). ASTRA 7 software (Wyatt Technology)
was used for data processing and result analysis. A dn/dc value of 0.185 ml/g
(typical of proteins) was assumed for calculations.
Antibody production and validation. Polyclonal antibodies against adhesin P1
were produced by Eurogentec. Briefly, rats were injected with peptides
Lys1376–Asp1521 or Ala1400–Asp1521 and bleeds were collected at day 28. Pre-
immunization bleeds were also collected as negative controls. Specificity of the
polyclonal antibodies was tested by western blot against the recombinant peptides
and protein extract of Mycoplasma cells. The dilution used for each antibody
was 1:500.
The production of polyclonal antibodies has complied with ethical regulations
for animal testing and research. It complies with the following association’s
requirements: Federation of European Laboratory animal Science Associations and
UK Home Office Animals Scientific Procedures Act.
The regulations followed by Eurogentec are: 2010/63/EU and 01/2005/EU.
Quantitative adhesion assay. M. pneumoniae (ATCC 29343) was grown in a T75
flask in Hayflick medium during 24 h, harvested by scraping, and resuspended in
Hayflick medium to a final concentration of 107 cells/ml. Incubation, during 1 h at
room temperature on a rotating wheel, of 1 ml of a cell suspension with sera (at 1,
3, 6, and 10% concentrations) containing polyclonal antibodies raised against
peptides Lys1376–Asp1521 or Ala1400–Asp1521, in presence or absence of 2 µg
from the corresponding peptide. A preimmunization serum was used as a negative
control. After incubation, cell suspensions were seeded in 24-well plates and
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incubated at 37 °C to allow cells adhere to the plastic. After 2 h, supernatants
(containing the fraction of the cells that did not adhere to the plastic) and attached
cells were collected and processed for gDNA extraction using MasterPure DNA
Purification Kit (EpiCentre #MCD85201). Samples were obtained in triplicate, and
the relative amount of cells was quantified by qPCR with SYBR Green PCR Master
Reagent (Thermo #4367659), using a LightCycler 480 Real-Time PCR machine
(Roche) with the following conditions: denaturation at 95 °C for 10 s; 40 cycles of
amplification of 95 °C for 15 s and 60 °C for 1 min; melting curve at 95° for 15 s,
60 °C for 15 s, 95° continuous. The following oligonucleotides were used: qPCR
Myco FW 5′-ACGATGATTACAGGCGGTTC-3′ and qPCR Myco RV 5′- GTTG
GTGGCCTCTTGTTGAT-3′.
Immunoassays. Diagnostic of M. pneumoniae was conducted using the Liaison M.
pneumoniae IgG, IgM kit (DiaSorin) using a 1/100 dilution of the patient sera.
Indirect ELISA assays were performed on 96-well plates Immulon 4 HBX 96-well
plates (ThermoFisher) incubating 1 µg of each antigen at 4 °C overnight. 1/100
dilutions of each patient serum were added to the plate and detected using an anti-
human IgG antibody conjugated with HRP (Thermofisher Scientific). Upon
incubation for 30 min with 100 µl of substrate (Thermofisher Scientific), 100 µl of
sulfuric acid 25% was added to stop the reaction and absorbance was read at 450
nm on a Triturus ELISA instrument (Grifols) device. Reference filter was set at 620
nm.
Ethical approval. Ethical approval for the study was obtained from the Ethics
Committees for Research with Drugs from the Parc Taulí (Ref 2019/664) and Vall
d’Hebron University Hospitals (PR(AG)24/2020).
Inductive coupled plasma–mass spectrometry (ICP–MS). Samples were diges-
ted with 1 ml of HNO3 plus 0.5 ml of H2O2 in the closed teflon reactor during 24 h
at 90 °C. The Zn measure was realized with ICP–MS in an instrument Agilent
7500ce with respect to a calibration line prepared by dilution from a ZN standard
solution (Inorganic Ventures).
Surface plasmon resonance. Binding kinetics were determined by SPR using a
Biacore 3000 biosensor platform (GE Biosystems) equipped with a research-grade
streptavidin-coated biosensor chip SA. The chip was preconditioned with three 1-
min injections of 1M NaCl and 50 mM NaOH. Subsequently, the second and third
flow cells of the chip were loaded, respectively, with oligosaccharides 6SL-PAA-
biotin and 3SL-PAA-biotin (Carbosynth) at 10 µg/ml diluted in 20 mM TRIS pH
7.4, 150 mM NaCl, and 0.05 % tween20. It is noteworthy to mention that the
ligands used contains a long polyacrylamide chain connecting the biotinylated
chemically linked tag with the oligosaccharides, which should avoid most steric
clashes between biotin and the P1 and P40/P90 samples used. The immobilization
levels acquired were at ∼200 response units and the first cell was left blank to serve
as a reference. A series of diluted concentrations were injected using a flow rate of
30 µl/min at 25 °C (0.9, 1.9, 3.7, and 7.5 µM of P40/P90 for 6SL titration and 1.0,
2.0, 4.0, 16.0, and 32.0 µM of both P40/P90 and P1 for 3SL titration). The proteins
were allowed to associate and dissociate for 60 and 120 s, respectively, for P1 and
120 and 240 s, respectively, for P40/P90. Dissociations were followed by a regen-
eration step of 30 s with 0.05% SDS at 30 µl/min. The data were fitted assuming a
Langmuir 1:1 binding model using BiaEvaluation 3.1 software to determine the
equilibrium dissociation constant KD.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Atomic coordinates and structure factors for the reported crystal structures of P1, P40/
P90, and the P40/P90-3SL and P40/P90-6SL complexes have been deposited into the
Protein Data Bank (PDB) under accession codes 6RC9, 6RJ1, 6TLZ, and 6TM0,
respectively. Cryo-EM density has been deposited in the EM Data Base under the
accession code EMD-30233. Atomic coordinates of the Cryo-EM structure have been
deposited in the PDB under the accession code 7BWM. Source data are provided with
this paper. Other data are available from the corresponding authors upon reasonable
request.
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